Huntsman Cancer Institute is an NCI-designated cancer research facility and hospital located on the campus of the University of Utah in Salt Lake City, Utah. It is the only National Cancer Institute-designated Comprehensive Cancer Center in the Intermountain West.

During the past decade, Center for Quantitative Cancer Imaging at Huntsman Cancer Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute" #1 collaborator was "Precision For Medicine" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute" are "Brain Metastases" (2 trials). Many other conditions were trialed in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute" in a lesser frequency.

Most popular intervention types in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "18F fluciclovine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Center for Quantitative Cancer Imaging at Huntsman Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Center for Quantitative Cancer Imaging at Huntsman Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Quantitative Cancer Imaging at Huntsman Cancer Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".